Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
Inloggen

Welkom bij THIM Hogeschool voor Fysiotherapie & Bohn Stafleu van Loghum

THIM Hogeschool voor Fysiotherapie heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen. Je kunt je links eenvoudig registreren. Met deze gegevens kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL. Heb je een vraag, neem dan contact op met helpdesk@thim.nl.

» Andere revante producten voor THIM studenten en medewerkers.

Registreer

Om ook buiten de locaties van THIM, thuis bijvoorbeeld, van Mijn BSL gebruik te kunnen maken, moet je jezelf eenmalig registreren. Dit kan alleen vanaf een computer op een van de locaties van THIM.

Eenmaal geregistreerd kun je thuis of waar ook ter wereld onbeperkt toegang krijgen tot Mijn BSL.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Inloggen
Top
Quality of Life Research
Gepubliceerd in:

01-03-2015

The relationship of health-related quality of life and treatment outcome during inpatient treatment of depression

Auteurs: Stephan Köhler, Theresa Unger, Sabine Hoffmann, Arthur Mackert, Barbara Ross, Thomas Fydrich

Gepubliceerd in: Quality of Life Research | Uitgave 3/2015

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

Health-related quality of life (HRQoL) is important for long-term social functioning. It is considerably reduced in patients with depression. We studied the impact of HRQoL on treatment outcome in patients with unipolar depression. Furthermore, we analysed factors associated with HRQoL in inpatients with unipolar depression.

Methods

One hundred and eighty patients suffering from major depressive disorder were evaluated during their inpatient treatment by assessing admission and discharge depression severity and their HRQoL, using the Medical Outcomes Study 12-item Short Form (SF-12). Baseline and treatment variables associated with HRQoL were examined by regression analysis. Primary outcome measures were the Hamilton Rating Scale and the Beck Depression Inventory.

Results

HRQoL improved significantly during inpatient treatment. Lower HRQoL outcomes were strongly associated with higher age, somatic comorbidities, a recurrent depressive disorder and stronger depressive symptoms at admission. Additionally, patients with a complex treatment situation (high number of medications, antidepressant switch) showed stronger impairment of HRQoL. Personality disorders and additional psychotherapy did not predict HRQoL.

Conclusion

The inpatient treatment resulted in an increase of the SF-12 scores, although to a lower extent than depressive symptoms. Several factors negatively influence HRQoL, such as the presence of somatic and axis I psychiatric comorbiditites and a recurrent or severe depressive episode. Targeting somatic comorbidities in patients with unipolar depression seem to play an important role for HRQoL.
vorige artikel A qualitative study of the impact of severe asthma and its treatment showing that treatment burden is neglected in existing asthma assessment scales
volgende artikel Low functional status as a predictor of incidence of emotional disorders in the general population
Literatuur
1.
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 593–602.CrossRefPubMed
2.
Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006). Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet, 367(9524), 1747–1757.CrossRefPubMed
3.
4.
Hirschfeld, R. M., Montgomery, S. A., Keller, M. B., Kasper, S., Schatzberg, A. F., Moller, H. J., et al. (2000). Social functioning in depression: A review. Journal of Clinical Psychiatry, 61(4), 268–275.CrossRefPubMed
5.
Angermeyer, M. C., Holzinger, A., Matschinger, H., & Stengler-Wenzke, K. (2002). Depression and quality of life: Results of a follow-up study. International Journal of Social Psychiatry, 48(3), 189–199.CrossRefPubMed
6.
Berlim, M. T., Pargendler, J., Brenner, J., & Fleck, M. P. (2007). Significant improvement in the quality of life of Brazilian depressed outpatients 12 weeks following the start of antidepressants. Psychiatry Research, 153(3), 253–259.CrossRefPubMed
7.
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007). Depression, chronic diseases, and decrements in health: Results from the World Health Surveys. Lancet, 370(9590), 851–858.CrossRefPubMed
8.
Lim, L., Jin, A. Z., & Ng, T. P. (2012). Anxiety and depression, chronic physical conditions, and quality of life in an urban population sample study. Social Psychiatry and Psychiatric Epidemiology, 47(7), 1047–1053.CrossRefPubMed
9.
Ravindran, A. V., Matheson, K., Griffiths, J., Merali, Z., & Anisman, H. (2002). Stress, coping, uplifts, and quality of life in subtypes of depression: A conceptual frame and emerging data. Journal of Affective Disorders, 71(1–3), 121–130.CrossRefPubMed
10.
Sobocki, P., Ekman, M., Agren, H., Runeson, B., & Jonsson, B. (2006). The mission is remission: Health economic consequences of achieving full remission with antidepressant treatment for depression. International Journal of Clinical Practice, 60(7), 791–798.CrossRefPubMed
11.
Pyne, J. M., Bullock, D., Kaplan, R. M., Smith, T. L., Gillin, J. C., Golshan, S., et al. (2001). Health-related quality-of-life measure enhances acute treatment response prediction in depressed inpatients. Journal of Clinical Psychiatry, 62(4), 261–268.CrossRefPubMed
12.
ten Doesschate, M. C., Koeter, M. W., Bockting, C. L., & Schene, A. H. (2010). Health related quality of life in recurrent depression: A comparison with a general population sample. Journal of Affective Disorders, 120(1–3), 126–132.CrossRefPubMed
13.
Rapaport, M. H., Clary, C., Fayyad, R., & Endicott, J. (2005). Quality-of-life impairment in depressive and anxiety disorders. American Journal of Psychiatry, 162(6), 1171–1178.CrossRefPubMed
14.
Kroenke, K. (2003). Patients presenting with somatic complaints: Epidemiology, psychiatric comorbidity and management. International Journal of Methods in Psychiatric Research, 12(1), 34–43.CrossRefPubMed
15.
Tylee, A., & Gandhi, P. (2005). The importance of somatic symptoms in depression in primary care. Primary Care Companion to the Journal of Clinical Psychiatry, 7(4), 167–176.CrossRefPubMedCentralPubMed
16.
Judd, L. L., Akiskal, H. S., Maser, J. D., Zeller, P. J., Endicott, J., Coryell, W., et al. (1998). Major depressive disorder: A prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. Journal of Affective Disorders, 50(2–3), 97–108.CrossRefPubMed
17.
Bair, M. J., Robinson, R. L., Eckert, G. J., Stang, P. E., Croghan, T. W., & Kroenke, K. (2004). Impact of pain on depression treatment response in primary care. Psychosomatic Medicine, 66(1), 17–22.CrossRefPubMed
18.
Reed, C., Monz, B. U., Perahia, D. G., Gandhi, P., Bauer, M., Dantchev, N., et al. (2009). Quality of life outcomes among patients with depression after 6 months of starting treatment: Results from FINDER. Journal of Affective Disorders, 113(3), 296–302.CrossRefPubMed
19.
Matsunaga, M., Okamoto, Y., Suzuki, S., Kinoshita, A., Yoshimura, S., Yoshino, A., et al. (2010). Psychosocial functioning in patients with treatment-resistant depression after group cognitive behavioral therapy. BMC Psychiatry, 10, 22.CrossRefPubMedCentralPubMed
20.
Caruso, R., Rossi, A., Barraco, A., Quail, D., & Grassi, L. (2010). The Factors Influencing Depression Endpoints Research (FINDER) study: Final results of Italian patients with depression. Annals of General Psychiatry, 9, 33.CrossRefPubMedCentralPubMed
21.
Wells, K. B., Sherbourne, C., Schoenbaum, M., Duan, N., Meredith, L., Unutzer, J., et al. (2000). Impact of disseminating quality improvement programs for depression in managed primary care: A randomized controlled trial. JAMA, 283(2), 212–220.CrossRefPubMed
22.
Bech, P. (2005). Social functioning: Should it become an endpoint in trials of antidepressants? CNS Drugs, 19(4), 313–324.CrossRefPubMed
23.
Trivedi, M. H. (2001). Sensitizing clinicians and patients to the social and functional aspects of remission. Journal of Clinical Psychiatry, 62(Suppl 19), 32–35.PubMed
24.
Wisniewski, S. R., Rush, A. J., Bryan, C., Shelton, R., Trivedi, M. H., Marcus, S., et al. (2007). Comparison of quality of life measures in a depressed population. The Journal of Nervous and Mental Disease, 195(3), 219–225.CrossRefPubMed
25.
Frank, E., Prien, R. F., Jarrett, R. B., Keller, M. B., Kupfer, D. J., Lavori, P. W., et al. (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Archives of General Psychiatry, 48(9), 851–855.CrossRefPubMed
26.
Härter, M., Klesse, C., Bermejo, I., Schneider, F., & Berger, M. (2010). Unipolar depression: Diagnostic and therapeutic recommendations from the current S3/National Clinical Practice Guideline. Deutsches ärzteblatt International, 107(40), 700–708.PubMedCentralPubMed
27.
Hiller, W., Zaudig, M., & Mombour, W. (2005). IDCL: ICD-10 Checklists. Göttingen: Hogrefe.
28.
29.
Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561–571.CrossRefPubMed
30.
Endicott, J., Spitzer, R. L., Fleiss, J. L., & Cohen, J. (1976). The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry, 33(6), 766–771.CrossRefPubMed
31.
Guy, W. (1976). Clinical Global Impressions (CGI). In: ECDEU Assessment Manual for Psychopharmacology US Department of Health, Education, and Welfare Publication (ADM) 76–338 (pp. 218–222). Rockville, MD: National Institute of Mental Health.
32.
First, M., Gibbon, M., & Spitzer, R. (1996). Structured clinical interview for DSM-IV axis II disorders. New York NY: Biometrics Research Dept, NewYork State Psychiatric Institute.
33.
Ware, J, Jr, Kosinski, M., & Keller, S. D. (1996). A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34(3), 220–233.CrossRefPubMed
34.
Collegium Internationale Psychiatriae Scalarum (CIPS). (2005). Internationale Skalen für Psychiatrie. Göttingen: Beltz Test.
35.
Ware, J. E., Kosinski, M., & Keller, S. D. (1995). SF-12: How to score the SF-12 physical and mental health summary scales (2nd ed.). Boston: The Health Institute, New England Medical Center.
36.
CIPS. (2005). International scales for psychiatry. Göttingen: Beltz Test GmbH.
37.
38.
Seemüller, F., Riedel, M., Obermeier, M., Bauer, M., Adli, M., Kronmüller, K., et al. (2010). Outcomes of 1014 naturalistically treated inpatients with major depressive episode. European Neuropsychopharmacology, 20(5), 346–355.CrossRefPubMed
39.
Daly, E. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Gaynes, B. N., Warden, D., et al. (2010). Health-related quality of life in depression: A STAR*D report. Annals of Clinical Psychiatry, 22(1), 43–55.PubMed
40.
Garcia-Campayo, J., Ayuso-Mateos, J. L., Caballero, L., Romera, I., Aragones, E., Rodriguez-Artalejo, F., et al. (2008). Relationship of somatic symptoms with depression severity, quality of life, and health resources utilization in patients with major depressive disorder seeking primary health care in Spain. Primary Care Companion to the Journal of Clinical Psychiatry, 10(5), 355–362.CrossRefPubMedCentralPubMed
41.
Bauer, M., Monz, B. U., Montejo, A. L., Quail, D., Dantchev, N., Demyttenaere, K., et al. (2008). Prescribing patterns of antidepressants in Europe: Results from the Factors Influencing Depression Endpoints Research (FINDER) study. European Psychiatry, 23(1), 66–73.CrossRefPubMed
42.
Peveler, R., Kendrick, T., Buxton, M., Longworth, L., Baldwin, D., Moore, M., et al. (2005). A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine. Health Technol Assess, 9(16), 1–134, iii.
43.
Dunner, D. L., Kwong, W. J., Houser, T. L., Richard, N. E., Donahue, R. M., & Khan, Z. M. (2001). Improved health-related quality of life and reduced productivity loss after treatment with bupropion sustained release: A study in patients with major depression. Primary Care Companion to the Journal of Clinical Psychiatry, 3(1), 10–16.CrossRefPubMedCentralPubMed
44.
Kruijshaar, M. E., Hoeymans, N., Bijl, R. V., Spijker, J., & Essink-Bot, M. L. (2003). Levels of disability in major depression: Findings from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Journal of Affective Disorders, 77(1), 53–64.CrossRefPubMed
45.
Kennedy, N., Foy, K., Sherazi, R., McDonough, M., & McKeon, P. (2007). Long-term social functioning after depression treated by psychiatrists: A review. Bipolar Disorders, 9(1–2), 25–37.CrossRefPubMed
46.
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Warden, D., McKinney, W., Downing, M., et al. (2006). Factors associated with health-related quality of life among outpatients with major depressive disorder: A STAR*D report. Journal of Clinical Psychiatry, 67(2), 185–195.CrossRefPubMed
47.
Köhler, S., Unger, T., Hoffmann, S., Steinacher, B., Fydrich, T., & Bschor, T. (2013). Comparing augmentation with non-antidepressants over sticking to antidepressants after treatment failure in depression: A naturalistic study. Pharmacopsychiatry, 46(2), 69–76.PubMed
48.
Ruhe, H. G., Huyser, J., Swinkels, J. A., & Schene, A. H. (2006). Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: A systematic review. Journal of Clinical Psychiatry, 67(12), 1836–1855.CrossRefPubMed
Metagegevens
Titel
The relationship of health-related quality of life and treatment outcome during inpatient treatment of depression
Auteurs
Stephan Köhler
Theresa Unger
Sabine Hoffmann
Arthur Mackert
Barbara Ross
Thomas Fydrich
Publicatiedatum
01-03-2015
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 3/2015
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-014-0811-8

Andere artikelen Uitgave 3/2015

Cross-cultural adaptation and validation of the Neck Bournemouth Questionnaire in the Italian population

Low functional status as a predictor of incidence of emotional disorders in the general population

Response shift in the presence of missing data

  • Commentary

Estimating the minimum important change in the 15D scores

Method variation in the impact of missing data on response shift detection

  • Response Shift methods

Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO